Gene · 2290
Papers3,284
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,284
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinicopathological significance of SOX2 and FOXG1 expression patterns in ovarian immature teratomas]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39648002 | PubTator, text mining | PubMed |
| Hybrids of Membrane-Translocating Antimicrobial Peptides Show Enhanced Activity through Membrane Permeabilization. | ACS Med Chem Lett | 2024 | 39563817 | PubTator, text mining | PubMed |
| Altered expression of Csnk1a1p in Autism Spectrum Disorder in Iranian population: case-control study. | Sci Rep | 2024 | 39550379 | PubTator, text mining | PubMed |
| Manufacturing Uniform Cerebral Organoids for Neurological Disease Modeling and Drug Evaluation. | Biomater Res | 2024 | 39507522 | PubTator, text mining | PubMed |
| Modelling quiescence exit of neural stem cells reveals a FOXG1-FOXO6 axis. | Dis Model Mech | 2024 | 39499086 | PubTator, text mining | PubMed |
| OSBPL2 inhibition leads to apoptosis of cochlea hair cells in age-related hearing loss by inhibiting the AKT/FOXG1 signaling pathway. | Aging (Albany NY) | 2024 | 39475791 | PubTator, text mining | PubMed |
| Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition. | Pharmaceuticals (Basel) | 2024 | 39458997 | PubTator, text mining | PubMed |
| PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice. | Int J Mol Sci | 2024 | 39409184 | PubTator, text mining | PubMed |
| Validation of non-destructive morphology-based selection of cerebral cortical organoids by paired morphological and single-cell RNA-seq analyses. | Stem Cell Reports | 2024 | 39393360 | PubTator, text mining | PubMed |
| BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening. | Cancer Genet | 2024 | 39213700 | PubTator, text mining | PubMed |
| Exome sequencing reveals neurodevelopmental genes in simplex consanguineous Iranian families with syndromic autism. | BMC Med Genomics | 2024 | 39103847 | PubTator, text mining | PubMed |
| Saikosaponin-d mediates FOXG1 to reverse docetaxel resistance in prostate cancer through oxidative phosphorylation. | Mutat Res | 2024 | 39098234 | PubTator, text mining | PubMed |
| Evaluation of seizure semiology, genetics, magnetic resonance imaging, and electroencephalogram findings in children with Rett syndrome: A multicenter retrospective study. | Epilepsy Res | 2024 | 39003968 | PubTator, text mining | PubMed |
| FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma. | Cancer Sci | 2024 | 38932521 | PubTator, text mining | PubMed |
| Massively parallel in vivo Perturb-seq reveals cell-type-specific transcriptional networks in cortical development. | Cell | 2024 | 38772369 | PubTator, text mining | PubMed |
| Menin Deficiency Induces Autism-Like Behaviors by Regulating Foxg1 Transcription and Participates in Foxg1-Related Encephalopathy. | Adv Sci (Weinh) | 2024 | 38582517 | PubTator, text mining | PubMed |
| Prevalence of Endocrinopathies in a Cohort of Patients with Rett Syndrome: A Two-Center Observational Study. | Genes (Basel) | 2024 | 38540345 | PubTator, text mining | PubMed |
| A novel frameshift mutation of FOXG1-induced congenital variant of Rett syndrome: A case report. | Asian J Surg | 2024 | 38538395 | PubTator, text mining | PubMed |
| Yield and Utility of Routine Epilepsy Panel Genetic Testing Among Young Patients With Seizures. | J Child Neurol | 2024 | 38528770 | PubTator, text mining | PubMed |
| HBMIRT: A SAS macro for estimating uni- and multidimensional 1- and 2-parameter item response models in small (and large!) samples. | Behav Res Methods | 2024 | 38519726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2290/papers?page=6